[Antinuclear factors during D-penicillamine therapy].
D000974:Antibodies, Antinuclear / Q000032:analysis*; D006801:Humans; D010396:Penicillamine / Q000009:adverse effects / Q000627:therapeutic use*; D011507:Proteinuria / Q000139:chemically induced
D000974:Antibodies, Antinuclear; D010396:Penicillamine
Antinukleäre Faktoren während einer D-Penicillamintherapie